88 related articles for article (PubMed ID: 1493048)
1. Regulatory elements in the human immunodeficiency virus type 1 long terminal repeat LTR (HIV-1) responsive to steroid hormone stimulation.
Kolesnitchenko V; Snart RS
AIDS Res Hum Retroviruses; 1992 Dec; 8(12):1977-80. PubMed ID: 1493048
[TBL] [Abstract][Full Text] [Related]
2. Role of glucocorticoid receptor binding sites in the human immunodeficiency virus type 1 long terminal repeat in steroid-mediated suppression of HIV gene expression.
Mitra D; Sikder SK; Laurence J
Virology; 1995 Dec; 214(2):512-21. PubMed ID: 8553553
[TBL] [Abstract][Full Text] [Related]
3. HIV-1 long terminal repeat modulation by glucocorticoids in monocytic and lymphocytic cell lines.
Russo FO; Patel PC; Ventura AM; Pereira CA
Virus Res; 1999 Oct; 64(1):87-94. PubMed ID: 10500286
[TBL] [Abstract][Full Text] [Related]
4. The Epstein-Barr virus DNA polymerase transactivates the human immunodeficiency virus type 1 5' long terminal repeat.
Lin JC
Biochem Biophys Res Commun; 1993 Aug; 195(1):242-9. PubMed ID: 8395825
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of the basal-level activity of HIV-1 long terminal repeat by HIV-1 nucleocapsid protein.
Zhang JL; Sharma PL; Crumpacker CS
Virology; 2000 Mar; 268(2):251-63. PubMed ID: 10704334
[TBL] [Abstract][Full Text] [Related]
6. Basal and Tat-transactivated expression from the human immunodeficiency virus type 1 long terminal repeat in human placental trophoblast rules out promoter-enhancer activation as the partial block to viral replication.
Zachar V; Ebbesen P; Thomas RA; Zacharova V; Goustin AS
J Gen Virol; 1994 Jun; 75 ( Pt 6)():1461-8. PubMed ID: 8207411
[TBL] [Abstract][Full Text] [Related]
7. Response of human immunodeficiency virus long terminal repeat to growth factors and hormones.
Spandidos DA; Zoumpourlis V; Kotsinas A; Tsiriyotis C; Sekeris CE
Anticancer Res; 1990; 10(5A):1241-5. PubMed ID: 2241099
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication.
McAllister JJ; Phillips D; Millhouse S; Conner J; Hogan T; Ross HL; Wigdahl B
Virology; 2000 Sep; 274(2):262-77. PubMed ID: 10964770
[TBL] [Abstract][Full Text] [Related]
9. Glucocorticoids suppress human immunodeficiency virus type-1 long terminal repeat activity in a cell type-specific, glucocorticoid receptor-mediated fashion: direct protective effects at variance with clinical phenomenology.
Kino T; Kopp JB; Chrousos GP
J Steroid Biochem Mol Biol; 2000 Dec; 75(4-5):283-90. PubMed ID: 11282284
[TBL] [Abstract][Full Text] [Related]
10. Activation of the human immunodeficiency virus type I long terminal repeat by 1 alpha,25-dihydroxyvitamin D3.
Nevado J; Tenbaum SP; Castillo AI; Sánchez-Pacheco A; Aranda A
J Mol Endocrinol; 2007 Jun; 38(6):587-601. PubMed ID: 17556530
[TBL] [Abstract][Full Text] [Related]
11. Retinoblastoma gene inhibits transactivation of HIV-LTR linked gene expression upon co-transfection in He La cells.
Prasad MV; Shanmugam G
Biochem Mol Biol Int; 1993 Jan; 29(1):57-62. PubMed ID: 8490568
[TBL] [Abstract][Full Text] [Related]
12. Regulation of NF-kappaB and HIV-1 LTR activity in mouse L cells by ultraviolet radiation: LTR trans-activation in a nonirradiated genome in heterokaryons.
Miller SC; Taylor A; Watanabe K; Mok K; Torti FM
Exp Cell Res; 1997 Jan; 230(1):9-21. PubMed ID: 9013701
[TBL] [Abstract][Full Text] [Related]
13. High expression of exogenous cDNAs directed by HIV-1 long terminal repeat in human cells constitutively producing HIV-1 tat and adenovirus E1A/E1B.
Negrini M; Rimessi P; Sabbioni S; Caputo A; Balboni PG; Gualandri R; Manservigi R; Grossi MP; Barbanti-Brodano G
Biotechniques; 1991 Mar; 10(3):344-53. PubMed ID: 1829615
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional activation of the human immunodeficiency virus long terminal repeat sequences by tumor necrosis factor.
Zoumpourlis V; Eliopoulos AG; Spandidos DA
Anticancer Res; 1992; 12(6B):2065-8. PubMed ID: 1295450
[TBL] [Abstract][Full Text] [Related]
15. Identification of human cytomegalovirus target sequences in the human immunodeficiency virus long terminal repeat. Potential role of IE2-86 binding to sequences between -120 and -20 in promoter transactivation.
Yurochko AD; Huong SM; Huang ES
J Hum Virol; 1999; 2(2):81-90. PubMed ID: 10225210
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of relative promoter strengths of the HIV-1-LTR and a chimeric RSV-LTR in T lymphocytic cells and peripheral blood mononuclear cells: promoters for anti-HIV-1 gene therapies.
Mukhtar M; Duan L; Bagasra O; Pomerantz RJ
Gene Ther; 1996 Aug; 3(8):725-30. PubMed ID: 8854098
[TBL] [Abstract][Full Text] [Related]
17. Regulation of HIV-1 gene expression by NF-IL6.
Tesmer VM; Bina M
J Mol Biol; 1996 Sep; 262(3):327-35. PubMed ID: 8844998
[TBL] [Abstract][Full Text] [Related]
18. The human immunodeficiency virus long terminal repeat contains sequences showing partial homology to glucocorticoid responsive elements.
Katsanakis CD; Sekeris CE; Spandidos DA
Anticancer Res; 1991; 11(1):381-3. PubMed ID: 2018375
[TBL] [Abstract][Full Text] [Related]
19. Essential role of NF-kappa B in transactivation of the human immunodeficiency virus long terminal repeat by the human cytomegalovirus 1E1 protein.
Kim S; Yu SS; Kim VN
J Gen Virol; 1996 Jan; 77 ( Pt 1)():83-91. PubMed ID: 8558131
[TBL] [Abstract][Full Text] [Related]
20. U5 region of the human immunodeficiency virus type 1 long terminal repeat contains TRE-like cAMP-responsive elements that bind both AP-1 and CREB/ATF proteins.
Rabbi MF; Saifuddin M; Gu DS; Kagnoff MF; Roebuck KA
Virology; 1997 Jun; 233(1):235-45. PubMed ID: 9201233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
